Our Institutional Experience with Establishing a PSMA-Targeted Radioligand Therapy Service at Vanderbilt University Medical Center

被引：0
|
作者：
Ali, Hamideh Ale
Harris, DeAngelo [1 ]
Bradshaw, Marques [1 ]
Scherer, Philip [2 ]
机构：
[1] Vanderbilt Univ, Med Ctr, Nashville, TN USA
[2] Vanderbilt Univ, Nashville, TN USA
来源：
JOURNAL OF NUCLEAR MEDICINE | 2023年 / 64卷
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
P1399
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Individual radiosensitivity reflected by γ-H2AX and 53BP1 foci predicts outcome in PSMA-targeted radioligand therapy
    Liam Widjaja
    Rudolf A. Werner
    Elke Krischke
    Hans Christiansen
    Frank M. Bengel
    Natalia Bogdanova
    Thorsten Derlin
    European Journal of Nuclear Medicine and Molecular Imaging, 2023, 50 : 602 - 612
  • [32] Overview of selected completed prospective studies on PSMA-targeted radioligand therapy with [177Lu]Lu-PSMA-617 in metastatic castration-resistant prostate cancer
    Karimzadeh, Amir
    Lehnert, Wencke
    Koehler, Daniel
    Shenas, Farzad
    Kisters, Anna
    Apostolova, Ivayla
    Klutmann, Susanne
    Adam, Gerhard
    Sauer, Markus
    ROFO-FORTSCHRITTE AUF DEM GEBIET DER RONTGENSTRAHLEN UND DER BILDGEBENDEN VERFAHREN, 2025,
  • [33] Distinctive Clinical Features of Cerebral Amyloid Angiopathy Related Inflammation: the Vanderbilt University Medical Center Experience
    Eaton, James
    Schrag, Matthew
    Pawate, Siddharama
    NEUROLOGY, 2019, 92 (15)
  • [34] Salivary Gland Toxicity of PSMA-Targeted Radioligand Therapy with 177Lu-PSMA and Combined 225Ac- and 177Lu-Labeled PSMA Ligands (TANDEM-PRLT) in Advanced Prostate Cancer: A Single-Center Systematic Investigation
    Langbein, Thomas
    Kulkarni, Harshad R.
    Schuchardt, Christiane
    Mueller, Dirk
    Volk, Gerd Fabian
    Baum, Richard P.
    DIAGNOSTICS, 2022, 12 (08)
  • [35] Presymptomatic testing for Huntington Disease: Our experience at the University of Michigan Medical Center
    Petty, EM
    Uhlmann, W
    PERIODICUM BIOLOGORUM, 1998, 100 (03) : 289 - 298
  • [36] Safety of PSMA-Targeted Molecular Radioligand Therapy with 177Lu-PSMA-617: Results from the Prospective Multicenter Phase 2 Trial RESIST-PC (NCT03042312)
    Calais, Jeremie
    Czernin, Johannes
    Thin, Pan
    Gartmann, Jeannine
    Nguyen, Kathleen
    Armstrong, Wesley R.
    Allen-Auerbach, Martin
    Quon, Andrew
    Bahri, Shadfar
    Gupta, Pawan
    Gardner, Linda
    Dahlbom, Magnus
    He, Beilei
    Esfandiari, Rouzbeh
    Ranganathan, David
    Herrmann, Ken
    Eiber, Matthias
    Fendler, Wolfgang P.
    Delpassand, Ebrahim
    JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (10) : 1447 - 1456
  • [37] Evolution of an inpatient anticoagulant service: the University of California Davis Medical Center experience
    Dager, W.
    Roberts, A.
    Parker, P.
    White, R.
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (03) : 373 - 373
  • [38] TheraP-based Selection Criteria Do Not result in a Survival Benefit When Compared With VISION Trial Criteria in Prostate Cancer Patients Scheduled for PSMA-targeted Radioligand Therapy
    Michalski, K.
    Kosmala, A.
    Werner, R. A.
    Serfling, S.
    Seitz, A. K.
    Lapa, C.
    Buck, A. K.
    Hartrampf, P. E.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2023, 50 (SUPPL 1) : S649 - S649
  • [39] qPSMA: First semi-automatic tool for whole-body tumor burden assessment in prostate cancer PET imaging and preliminary evaluation for PSMA-targeted radioligand therapy
    Gafita, A.
    Bieth, M.
    Kroenke, M.
    Schwaiger, S.
    Heck, M.
    Tauber, R.
    D'Alessandria, C.
    Schwaiger, M.
    Weber, W.
    Eiber, M.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2018, 45 : S524 - S524
  • [40] Genomic characterization of metastatic castration-resistant prostate cancer patients undergoing PSMA radioligand therapy: A single-center experience
    Satapathy, Swayamjeet
    Das, Chandan K.
    Aggarwal, Piyush
    Sood, Ashwani
    Parihar, Ashwin S.
    Singh, Shrawan K.
    Mittal, Bhagwant R.
    PROSTATE, 2023, 83 (02): : 169 - 178
12345